Extracellular vesicles (EVs) are small membrane-bound vesicles released by most eukaryotic cells. They are present in various human and animal body fluids. The discovery of EVs dates back to the work of Pan and Johnstone, who identified them during platelet differentiation (1). Initially, EVs were thought to function primarily in cellular waste removal. However, subsequent research revealed that they contain major histocompatibility complex (MHC) molecules, indicating a potential role in antigen presentation (2, 3, 4).
Extracellular vesicles (EVs) are tiny, lipid-bound carriers. They are released by many eukaryotic cells (5)
Cell-released vesicles with membranous structures, collectively referred to as EVs are widely reported to be involved in cell-cell communication by their secretion and uptake (9).
Bacterial extracellular vesicles (EVs) are another weapon gut bacteria use to induce intestinal and extra-intestinal effects. Depending on which bacteria the EVs originate from, they promote pro- (EVs from pathogenic bacteria) or anti-inflammatory (EVS from commensal bacteria) responses (10).
Extraintestinally, EVs may prime neutrophils for inflammatory responses elicited by secondary stimuli (11)
Extracellular vesicles (EV) are membrane vesicles that are released from numerous cell types, including intestinal epithelial cells (exosomes) and bacteria (outer membrane vesicles (OMV), membrane vesicles) (12, 13, 14).
EVs carry specific cargos from infected cells. This makes them useful as biomarkers for diseases. Viruses can use the EV machinery to spread. EVs from infected cells can carry immune molecules. This helps in disease progression (5).
EV contain toxins, nucleic acids, proteins (including cytokines), and genetic material and are capable of crossing the BBB and influencing neuroinflammation and brain function (15).
Extracellular vesicles released by APCs carry surface MHC class I and class II molecules (16)
EVs are classified into three main types based on their size, content, and origin (5):
Microvesicles, ectosomes, oncosomes, apoptotic bodies, exosomes (17).
The formation of exosomes involves the invagination of the plasma membrane to create endosomes. Early endosomes develop into intraluminal vesicles (ILVs), which then fuse to form multivesicular bodies (MVBs). During this process, proteins, nucleic acids, and lipids are sorted, often utilizing the endosomal sorting complexes required for transport (ESCRT) (6). Interestingly, EVs can form with or without the involvement of ESCRT (7, 8), though the specific conditions that favor one pathway over the other remain unclear. MVBs typically contain ILVs ranging from 30 to 100 nm in size (18).
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
see also:
Blood Brain Barrier (BBB)